ARTICLE | Company News
SkyePharma DepoFoam deal with Amgen
April 4, 2000 7:00 AM UTC
SkyePharma (LSE:SKP; SKYE) will use its DepoFoam sustained release injectable delivery system with an undisclosed AMGN product. Under the first phase of the agreement, AMGN will complete its evaluation of the DepoFoam technology for use with its product. ...